EFTA01518898.pdf

CHISLAINE MAXWELL ACCT. For the Period 9/1/I3 to 9/30/13 Equity Summary Beginning Ending Change Current Asset Categories Asset Categories Market Value Market Value In Value Allocation US Large Cap Equity 292.573.99 299.641.71 7.067,72 6% US Small/Mid Cap Equity 4.290.00 10.050.00 5.760.00 1% Non•US Equity 135.18 146.86 11.68 1% Unlined Stocks Preferred Stocks 445.152 00 444.174 00 (978.00) 9% Concentrated 8 Other Equity 213.721 50 215.609 00 1.887.50 4% Non-VS Equity US Sintitilisel Cap Equity Total Value $955,872.67 $969,621.57 513,748.90 21% Current Concentrated & Other EquilY \la rket Value/Cost Period Value Market Value 969,621 57 Tar. Cost 944,362 24 US Largo Cap Equity Unrealized Gall Loss 25,259 33 Estimated Annual Income 50.794 36 Accrued DI. deeds 7 305 33 Equity as a percentage of your portfolio 21 (s Yield 5.22% J.P.Morgan Account Page 5 n' 34 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-00046156 Chase CONFIDENTIAL SDNY_GM_00315354 EFTA01518898